[Congenital toxoplasmosis: prevention in the pregnant woman and management of the neonate].
The management of a pregnant women or a child infected by Toxoplasma gondii rests on the screening of pregnant women at risk of infection. Treatment is prescribed if an infection occurs. A prenatal diagnosis (detection of T. gondii in amniotic fluid) may be performed, a positive result leading to a reinforcement of the treatment. After birth, the follow-up of the child is needed in order to prevent and detect the sequellae, mainly ocular. For all these steps, the biological methods used to diagnose T. gondii infection are of paramount importance.
Pelloux
H
H
Département de pédiatrie, hôpital A Michallon, BP 217, 38043 Grenoble, France. HPelloux@chu-grenoble.fr
Fricker-Hidalgo
H
H
Pons
J C
JC
Bost-Bru
C
C
Brenier-Pinchart
M P
MP
Jouk
P S
PS
Ambroise-Thomas
P
P
D000328:Adult; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D002648:Child; D003049:Coccidiostats / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D015597:Pregnancy Complications, Parasitic / Q000175:diagnosis / Q000517:prevention & control*; D011739:Pyrimethamine / Q000627:therapeutic use; D015572:Spiramycin / Q000008:administration & dosage / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D013413:Sulfadoxine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000175:diagnosis / Q000517:prevention & control*; D014125:Toxoplasmosis, Congenital / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000981:Antiprotozoal Agents; D003049:Coccidiostats; D013411:Sulfadiazine; D015572:Spiramycin; D013413:Sulfadoxine; D011739:Pyrimethamine
Toxoplasmose congénitale: prévention chez la femme enceinte et prise en charge du nouveau-né.